IP Library Granted Patent US 8,940,333
Granted Patent B2
US 8,940,333 · App. 12/053,327 · Granted Jan 27, 2015

Amphiphilic block copolymers and nanoparticles comprising the same

Inventors: Ming-Fa Hsieh (Hsinchu, TW); Hsuen-Tseng Cha'ng (Kaohsiung, TW); Chin-Fu Chen (Taipei County, TW); Yuan-Chia Chang (Taipei, TW); Pei Kan (Hsinchu, TW); Tsai-Yu Lin (Changhua County, TW)
Assignee: Industrial Technology Research Institute
A61K9/5153A61K9/1075A61K47/34C08G63/664C08G63/6852C08G63/6882C08G63/6922Y10S977/906Y10S977/926
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,333
App. No.
12/053,327
Granted
Jan 27, 2015
Kind
B2
Abstract

An amphiphilic block copolymer is disclosed. The amphiphilic block copolymer includes one or more hydrophilic polymers, one or more hydrophobic polymer, and one or more zwitterions. The invention also provides a nanoparticle and carrier including the amphiphilic block copolymer for delivery of water insoluble drugs, growth factors, genes, or water insoluble cosmetic substances.

Claims (7)

1. A nanocarrier, comprising:

a nanoparticle comprising one or more block copolymers, wherein the block copolymer comprises a hydrophobic block, a hydrophilic block bonded to the hydrophobic block, and one zwitterion, wherein the zwitterion is only bonded to the hydrophobic block, and the zwitterion has one positive charge and one negative charge, wherein the nanoparticle has a hydrophobic interior and hydrophilic surface, wherein the hydrophobic block comprises polycaprolactone (PCL), polyvalerolactone (PVL), poly(lactide-co-glycolide) (PLGA), polylactic acid (PLA), polybutyrolactone (PBL), polyglycolide, or polypropiolactone (PPL), and the hydrophilic block comprises polyethylene glycol (PEG), hyaluronic acid (HA), or poly-γ-glutamic acid (PGA); and

an active substance encapsulated in the particle, wherein the nanoparticle has a diameter of about 20-1,000 nm.

2. The nanocarrier as claimed in claim 1 , wherein the active substance comprises water insoluble drugs, growth factors, genes, or water insoluble cosmetic substances.

3. The nanocarrier as claimed in claim 1 , wherein the active substance comprises camptothecin or derivatives thereof.

4. The nanocarrier as claimed in claim 1 , wherein the active substance comprises water insoluble ingredients for skin care.

5. The nanocarrier as claimed in claim 1 , wherein the nanocarrier is delivered by oral, transdermal administration, injection, or inhalation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2008
From: HSIEH, MING-FA; CHANG, HSUEN-TSENG; CHEN, CHIN-FU; CHANG, YUAN-CHIA; KAN, PEI; LIN, TSAI-YU
To: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
Reel/Frame 020689/0582 →
Continuity (2)
Continuation In Part 11268544 · Nov 8, 2005
Related Publication 20080166382A1 · Jul 10, 2008